ARI SODIUM IODIDE(I123) 100 Australia - English - Department of Health (Therapeutic Goods Administration)

ari sodium iodide(i123) 100

australian nuclear science and technology organisation t/a ansto - sodium iodide(123i), quantity: 100 mbq - capsule - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium bicarbonate; sodium thiosulfate pentahydrate; sodium hydroxide; purified water; sunset yellow fcf; quinoline yellow; titanium dioxide; brilliant blue fcf; carmoisine; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - sodium iodide [123] diagnostic capsules are for diagnostic imaging of thyroid tissue.

Sodium Iodide [123I] Curium 37 MBq/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sodium iodide [123i] curium 37 mbq/ml inj. sol. i.v. vial

curium belgium s.p.r.l.-b.v.b.a. - sodium iodide (123 i) 37 mbq/ml - solution for injection - 37 mbq/ml - sodium iodide (i-123) 37 mbq/ml - sodium iodide (123i)

ARI SODIUM IODIDE(I123) 1-12 MBq DIAGNOSTIC CAPSULE Australia - English - Department of Health (Therapeutic Goods Administration)

ari sodium iodide(i123) 1-12 mbq diagnostic capsule

australian nuclear science and technology organisation t/a ansto - sodium iodide(123i), quantity: 1 mbq - capsule - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium bicarbonate; sodium thiosulfate pentahydrate; sodium hydroxide; purified water; sunset yellow fcf; quinoline yellow; titanium dioxide; brilliant blue fcf; carmoisine; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - sodium iodide [123] diagnostic capsules are for diagnostic imaging of thyroid tissue.

Sodium Iodide (I-131) 200MBq/mL Therapy Solution oral liquid BP vial Australia - English - Department of Health (Therapeutic Goods Administration)

sodium iodide (i-131) 200mbq/ml therapy solution oral liquid bp vial

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 50 mbq - oral liquid, solution - excipient ingredients: sodium thiosulfate pentahydrate; water for injections; sodium bicarbonate - sodium iodide (131i) solution bp (for therapy) is indicated in the treatment of hyperthyroidism's and the detection and ablation of residual functioning thyroid tissue in differentiated thyroid carcinoma

Sodium Iodide (123I) GE Healthcare 37 MBq/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sodium iodide (123i) ge healthcare 37 mbq/ml inj. sol. i.v. vial

ge healthcare bv-srl - sodium iodide (123 i) 37 mbq/ml - solution for injection - 37 mbq/ml - sodium iodide (i-123) 37 mbq/ml - sodium iodide (123i)

Sodium Iodide (123I) GE Healthcare 3.7 MBq - 37 MBq hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sodium iodide (123i) ge healthcare 3.7 mbq - 37 mbq hard caps.

ge healthcare bv-srl - sodium iodide (123 i) - capsule, hard - 3,7-37 mbq - sodium iodide (i-123) - sodium iodide (123i)

Sodium Iodide (I-131) 2000MBq/mL Therapy solution oral liquid BP vial Australia - English - Department of Health (Therapeutic Goods Administration)

sodium iodide (i-131) 2000mbq/ml therapy solution oral liquid bp vial

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 1201 mbq - oral liquid, solution - excipient ingredients: sodium bicarbonate; sodium thiosulfate pentahydrate; water for injections - .

ANSTO Health Sodium Iodide (131-I) Therapy Capsules 50MBq Australia - English - Department of Health (Therapeutic Goods Administration)

ansto health sodium iodide (131-i) therapy capsules 50mbq

australian nuclear science and technology organisation t/a ansto - sodium iodide(131i), quantity: 50 mbq - capsule, hard - excipient ingredients: dibasic sodium phosphate; titanium dioxide; iron oxide yellow; water for injections; sodium bicarbonate; sodium thiosulfate pentahydrate; gelatin; sodium lauryl sulfate; silicon dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - .

SODIUM IODIDE I 131 DIAGNOSTIC- sodium iodide i 131 capsule United States - English - NLM (National Library of Medicine)

sodium iodide i 131 diagnostic- sodium iodide i 131 capsule

jubilant draximage inc., dba jubilant radiopharma - sodium iodide i-131 (unii: 29vco8achh) (iodide ion i-131 - unii:4gc1foq22u) - iodide ion i-131 100 mci - sodium iodide i 131 capsules diagnostic is indicated for use in adults for: - assessment of thyroid function using radioactive iodine (rai) uptake test - imaging the thyroid (scintigraphy) sodium iodide i 131 capsules diagnostic is contraindicated in pregnancy [see warnings and precautions (5.1) , use in specific populations (8.1) ]. risk summary sodium iodide i 131 capsules diagnostic is contraindicated in pregnancy because fetal exposure can lead to neonatal hypothyroidism, which in some cases is severe and irreversible. data from the published literature describe reports of neonatal thyroid abnormalities after fetal exposure, including agenesis of the thyroid and hypothyroidism (see clinical considerations, data ). no animal reproductive studies have been conducted. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnanc

SODIUM IODIDE I 123 capsule, gelatin coated United States - English - NLM (National Library of Medicine)

sodium iodide i 123 capsule, gelatin coated

cardinal health 418, inc - sodium iodide i-123 (unii: 29ukx3a616) (iodide ion i-123 - unii:98qpv8670c) - iodide ion i-123 100 uci - administration of sodium iodide i 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. to date there are no known contraindications to the use of sodium iodide i 123 capsules.